Wayne Joseph Riley - 24 Apr 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
Director
Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
24 Apr 2023
Net transactions value
$0
Form type
4
Filing time
26 Apr 2023, 17:10:38 UTC
Previous filing
17 Jun 2022
Next filing
06 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Award $0 +663 +5.3% $0.000000 13,265 24 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents common stock underlying 663 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2024 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.